Bank of America’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,187
Closed -$151K 6185
2025
Q4
$151K Buy
7,187
+2,310
+47% +$24.3K ﹤0.01% 5468
2025
Q3
$48.5K Sell
4,877
-363
-7% -$4.1K ﹤0.01% 6846
2025
Q2
$47.5K Sell
5,240
-122
-2% -$1.16K ﹤0.01% 6835
2025
Q1
$51.2K Sell
5,362
-1,900
-26% -$23K ﹤0.01% 6736
2024
Q4
$81.6K Buy
7,262
+1,322
+22% +$17.7K ﹤0.01% 6479
2024
Q3
$85.4K Sell
5,940
-388
-6% -$5.75K ﹤0.01% 6393
2024
Q2
$109K Buy
6,328
+693
+12% +$10.1K ﹤0.01% 6217
2024
Q1
$112K Buy
5,635
+793
+16% +$9.78K ﹤0.01% 6188
2023
Q4
$50.9K Buy
4,842
+1,473
+44% +$14.8K ﹤0.01% 6590
2023
Q3
$29.8K Sell
3,369
-1,691
-33% -$15.9K ﹤0.01% 6632
2023
Q2
$48.8K Sell
5,060
-703
-12% -$7.86K ﹤0.01% 6473
2023
Q1
$79.5K Sell
5,763
-3,647
-39% -$57.9K ﹤0.01% 6340
2022
Q4
$143K Sell
9,410
-6,651
-41% -$76.2K ﹤0.01% 6096
2022
Q3
$146K Buy
16,061
+5,416
+51% +$50.1K ﹤0.01% 6152
2022
Q2
$90K Buy
10,645
+4,432
+71% +$50.8K ﹤0.01% 6536
2022
Q1
$122K Buy
6,213
+3,110
+100% +$62.9K ﹤0.01% 6751
2021
Q4
$76K Buy
3,103
+1,152
+59% +$38.5K ﹤0.01% 7010
2021
Q3
$76K Buy
1,951
+1,181
+153% +$49.4K ﹤0.01% 6859
2021
Q2
$35K Buy
770
+397
+106% +$15K ﹤0.01% 6968
2021
Q1
$13K Sell
373
-1,724
-82% -$58.7K ﹤0.01% 6960
2020
Q4
$76K Buy
+2,097
New +$30.6K ﹤0.01% 6123

Other funds holding GLSI

Bank of America's GLSI Position: Q1 2026 in Review

Bank of America sold out of Greenwich LifeSciences (GLSI) in Q1 2026, closing a stake of 7,187 shares — an estimated $151K sold.

Bank of America first reported a position in GLSI in Q4 2020 and held it in 21 quarters. The position peaked at $151K in Q4 2025. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Bank of America reported no remaining Greenwich LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 7,187 Greenwich LifeSciences shares in Q1 2026, an estimated $151K.
  • Bank of America first reported a position in Greenwich LifeSciences in Q4 2020 and held it in 21 quarters.
  • Bank of America's Greenwich LifeSciences position peaked at $151K in Q4 2025.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.